Skip to content

Stimulate the Face to Improve Tactile Acuity on the Hand

Using a New Form of Cross-border Plasticity Within the Somatosensory Cortex: Stimulate the Face to Improve Tactile Acuity on the Hand

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04745247
Acronym
FACEHAND
Enrollment
25
Registered
2021-02-09
Start date
2021-02-01
Completion date
2023-02-21
Last updated
2021-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Face, RSS, Stroke

Brief summary

The study is a comparative study, to show that the administration of RSS stimulation on the face compared to the administration of strategy Sham stimulation, results in an temporary improvement in the tactile acuity of the hand in patients with tactile acuity impairment of the hand due to stroke.

Interventions

PROCEDURERSS

Repetitive somatosensory stimulation (RSS) applied on a small region of the face for 3 hours Sham Repetitive somatosensory stimulation (RSS) applied on a small region of the face for 3 hours : the number of stimuli is reduced compared to the effective RSS

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Double Blind

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age: 30-80 years old * Patients with diagnosis of unilateral (both right and left) ischemic or haemorrhagic stroke * Stroke event dates at least 3 months before the date of inclusion to the study * Mild-to-moderate sensory loss at the fingers of the hand contralateral to the stroke lesion (affected hand) * Capacity to provide written consent * Affiliation to a social security scheme Non-Inclusion Criteria: * Sensory impairment attributable to diabetes history, peripheral vascular disease or neuropathy * Severe speech disorder, global aphasia and/or cognitive impairment * Multiple stroke events * Bilateral stroke event * Hemineglect * History of neurological or psychiatric illness * Allergy to glue/tape * Male participants refusing to shave their moustaches or beards during the study * Other experimental procedure is forbidden during the weeks where the study is performed * Pregnant, parturient and lactating women * Persons deprived of their liberty * Adult persons subject to a legal protection measure: guardianship, curatorship * Congenital or acquired malformation/injury of the test finger

Exclusion criteria

* Impossibility to maintain hand position necessary for the tests due to severe spasticity * Severe impairment of the sensibility of the face preventing the administration of the RSS * Severe impairment of the absolute touch detection at the affected hand preventing measurement (threshold 512 mN)

Design outcomes

Primary

MeasureTime frameDescription
Tactile acuity : 2 point discrimination testWeek 3The Primary outcome measure is a composite of 2point discrimination test (2PDT) and Absolute threshold detection test after 3h of RSS. Spatial discrimination of the finger, Absolute threshold detection of the finger.
Tactile acuity : Absolute threshold detection test after 3h of RSSWeek 3The Primary outcome measure is a composite of 2point discrimination test (2PDT) and Absolute threshold detection test after 3h of RSS. Spatial discrimination of the finger, Absolute threshold detection of the finger.

Secondary

MeasureTime frameDescription
Jebsen-Taylor hand function test (JTHFT)Week 3Overall functionality of the hand, especially with regard to handling objects
Questionnaire comfort/ease to useWeek 3A self-reported assessment will be administered after the completion of testing procedure: a custom-made questionnaire including the ease of use, perceived sensations during RSS, easy positioning, pain on removal, positive and negative aspects of RSS, willing to continue using after release from the hospital, and willing to recommend to others.

Countries

France

Contacts

Primary ContactJacques LUAUTE, PU-PH
jacques.luaute@chu-lyon.fr4 78 86 50 23
Backup ContactGilles RODE, PU-PH
gilles.rode@chu-lyon.fr4 78 86 50 66

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026